Navigation Links
Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion;
Date:2/14/2012

al Brands selling and marketing expenses increased to $46.5 million, primarily as a result of field force expansions in the U.S. and Canada.

For the full year 2011, Global Brands segment net revenue increased to $441.0 million.

Global Brands segment adjusted gross margin for the full year 2011 was 78.7 percent, compared to 77.8 percent in 2010.Distribution Segment InformationThree Months EndedTwelve Months EndedDecember 31,December 31,(Unaudited; $ in millions)

2011201020112010Net revenue

$
251.4$
203.4$
776.2$
830.7Operating expenses:Cost of sales

214.6175.6652.7711.2Selling and marketing

20.817.077.270.3Segment contribution

$
.0$
.8$
46.3$
49.2Segment margin

6.4%5.3%6.0%5.9%Gross profit

$
36.8$
27.8$
23.5$
9.5Gross margin

14.6%13.7%15.9%14.4%Distribution segment net revenue for the fourth quarter 2011 increased 24 percent to $251.4 million compared to $203.4 million in the fourth quarter 2010. The increase was related to new third-party products launched during the fourth quarter. Distribution revenue consists only of sales of third-party products and excludes sales of Watson's brand and generic products.

Distribution segment adjusted gross margin was 14.6 percent in the fourth quarter 2011.

For the full year 2011, Distribution segment net revenues decreased 7 percent or $776.2 million, compared to $830.7 million in 2010. This decrease resulted from fewer new third party product launches.

Other Operating ExpensesConsolidated general and administrative expenses were $103.2 million in the fourth quarter 2011, a decrease of $19.2 million from the fourth quarter 2010.  The prior year period includes a $40 million reserve associated with drug pricing litigation.  Amortization expense for the fourth quarter 2011 was $151.3 million, compared to $52.0 million in fourth quarter 2010.  The increase was primarily the result of
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
(Date:8/29/2014)... 2014  United Therapeutics Corporation (NASDAQ: UTHR ... the District of New Jersey ... against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... that U.S. Patent No. 6,765,117 is both valid and ... its generic product until the expiration of that patent ...
(Date:8/29/2014)... -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... release its financial results for the fiscal 2014 fourth ... trading ends on Tuesday, September 9, 2014. ... p.m. U.S. EDT on Tuesday, September 9, 2014 (Wednesday, ... Company,s financial results, commercial partnerships, and future outlook.  The ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... , June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... announced today that it,will hold its 2010 Annual Meeting of Shareholders ... Beijing Time. The meeting will be held concurrently at No. 39,Shangdi ... 6 Temple Street, St.,John,s, Antigua . All shareholders of record ...
... The chairman of the U.S. bishops, Committee on Pro-Life Activities ... over its move toward approving a new drug that may induce ... letter to Dr. Margaret Hamburg , Commissioner of the ... criticized the FDA,s move to hold an advisory committee meeting ...
Cached Medicine Technology:Sinovac Schedules 2010 Annual Meeting of Shareholders 2Sinovac Schedules 2010 Annual Meeting of Shareholders 3Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 2Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 3Pro-Life Chair Voices 'Grave Concern' over FDA Plan to Approve Abortion Drug for 'Emergency Contraception' 4
(Date:8/29/2014)... (HealthDay News) -- Astronauts may be at heightened ... human immune systems, a new study suggests. That ... to asteroids, the moon and Mars undertaken in the ... space can be dangerous, NASA researchers say. They ... blood of International Space Station crew members remains relatively ...
(Date:8/29/2014)... 29, 2014 (HealthDay News) -- If you have bunions, taking ... treatment later, an expert says. A bunion is a ... when bone or tissue moves out of place and extends ... can cause debilitating pain and may require surgery to correct, ... Medical Center in Freehold, N.J. To prevent bunions, avoid ...
(Date:8/29/2014)... Elk Grove Village, IL (PRWEB) August 29, 2014 ... an innovator in hearing wellness solutions, is on its ... Sept. 15-17 at the San Diego Convention Center to ... for those who work in high-noise industrial environments. Etymotic’s ... among the hottest wearable technology devices at the show. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 LiveOps, Inc., ... service solutions, today announced that LiveOps has been selected ... Association's (MDA) Show of Strength Telethon for the third ... raises money and awareness to support MDA’s mission to ... aggressive and sometimes fatal muscle disease. This year’s program ...
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Prostate cancer ... good treatment decisions. This can lead to worse quality ... The study included 70 men, with a median age ... cancer. Poor understanding of the disease was associated ... less confidence that the treatment would be effective, the ...
Breaking Medicine News(10 mins):Health News:Spaceflight Might Weaken Astronauts' Immune Systems 2Health News:Take Steps to Control Bunions 2Health News:Etymotic’s Safe Listening Earphones and Earplugs Headed For The 2014 NSC Safety Expo 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Faced With Prostate Cancer, It Helps to Know the Enemy 2
... A new study published in the April issue of ... important role in the diagnosis and treatment of H1N1 influenza ... "Working in the emergency room is very stressful and physicians ... of cardiothoracic imaging in the Department of Radiology at Tel ...
... with heart attack, heart failure who didn,t undergo angioplasty ... 22 (HealthDay News) -- The anti-clotting drug Plavix is ... in patients with heart failure and heart attack who ... is a procedure to open blocked arteries. , Danish ...
... ... founder and sports mental trainer, Dan Vitchoff to help him prepare for the ISSF World ... Vitchoff and other experts to help him "train smart". The result for Richmond was the ... ...
... More attention should be paid to early memory loss, ... Memory and thinking skills can deteriorate quickly in people ... says a new study. , "These results show that ... Alzheimer,s disease is diagnosed, when people are just starting ...
... that chronic wounds might have trouble healing because of the actions ... as RNA. The Ohio State University researchers discovered in a ... blood flow lowers the production of a protein that is needed ... In a parallel experiment using human skin cells, the ...
... , State Legislators Vow to Protect Citizens from ObamaCare , ... , , ... ... WASHINGTON , March 22 ...
Cached Medicine News:Health News:Chest X-rays can help predict which H1N1 patients are at greatest risk 2Health News:Plavix Can Help Cut Death Risk in Certain Heart Patients 2Health News:PA Hypnosis Center Uses 'Smart Training' Sports Psychology for Gold Medal Success 2Health News:PA Hypnosis Center Uses 'Smart Training' Sports Psychology for Gold Medal Success 3Health News:Brain Function May Drop Quickly Before Alzheimer's 2Health News:Secret to healing chronic wounds might lie in tiny pieces of silent RNA 2Health News:Secret to healing chronic wounds might lie in tiny pieces of silent RNA 3Health News:Texas is 39th State to Defend Health Care Choice 2Health News:Texas is 39th State to Defend Health Care Choice 3
... The IMMULITE 2000, a continuous ... throughput of 200 tests per hour, ... efficiency and consolidation in medium- and ... package, with its self-explanatory graphical user ...
AIA - Nex.IA immunoassay analyzer state of the art automation and flexibility for high throughput immunoassay testing...
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... The Vitros 950 provides ... the needs of high volume ... of up to 900 results ... can store and perform the ...
Medicine Products: